HOME | COUNTRIES | CITIES | COMPANIES | SPORTS | CARS
news videos images websites wiki
 

Genentech NEWS

Tue, 19 Mar 2019 11:50:59 GMT
Affimed to receive milestone payment from Genentech; shares up 9% premarket  Seeking Alpha Affimed N.V. (AFMD) will receive a payment in an undisclosed amount on achieving preclinical milestone under its ongoing strategic collaboration with Genen. Seeking Alpha
Tue, 19 Mar 2019 13:18:59 GMT
Genentech's Tecentriq Wins Approval for ES-SCLC, Its Second of the Month  BioSpace Genentech's Tecentriq has picked up its second regulatory approval this month from the U.S. Food and Drug Administration.The approval marks the first new ... BioSpace
Mon, 18 Feb 2019 08:00:00 GMT
Executive Provides Mentorship and Promotes Diversity at Genentech  BioSpace There is a concept held dear by many that there is strength in diversity. At South San Francisco-based Genentech, that is a concept also embraced by Sara ... BioSpace
Mon, 11 Mar 2019 11:08:00 GMT
Roche and Genentech take global macular degeneration step  PharmaTimes Roche and Genentech have initiated two large global Phase III clinical trials testing the potential of faricimab in wet age-related macular degeneration. - News ... PharmaTimes
Fri, 08 Mar 2019 17:06:00 GMT
FDA Grants Genentech's Tecentriq in Combination With Abraxane Accelerated Approval for People With PD-L1-Positive, Metastatic Triple-Negative Breast Cancer  Business Wire Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), today announced the U.S. Food and Drug Administration (FDA) has granted ... Business Wire
Tue, 05 Mar 2019 08:00:00 GMT
Genentech's Herceptin Hylecta approved by FDA  BioPharma-Reporter.com Genentech receives US FDA approval on Herceptin Hylecta, a subcutaneous co-formulation using Halozyme's recombinant Enhanze technology, for the ... BioPharma-Reporter.com
Fri, 08 Mar 2019 13:01:00 GMT
Xencor Announces Closing of Research Collaboration and License Agreement with Genentech  Business Wire Xencor announced the closing of its collaboration agreement with Genentech to develop and commercialize novel IL-15 cytokine therapeutics. Business Wire
Tue, 19 Feb 2019 08:00:00 GMT
FDA Grants Priority Review to Genentech's Polatuzumab Vedotin in Previously Treated Aggressive Lymphoma  Business Wire Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), today announced that the U.S. Food and Drug Administration (FDA) has accepted ... Business Wire
Wed, 06 Mar 2019 08:00:00 GMT
FDA Accepts Genentech's Supplemental New Drug Application for XOFLUZA (baloxavir marboxil) for the Treatment of Influenza in People at High Risk of Complications  Business Wire Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), today announced that the U.S. Food and Drug Administration (FDA) has accepted ... Business Wire
Tue, 19 Mar 2019 07:53:38 GMT
Global Atezolizumab Market Outlook with Leading Vendors are Genentech , and many more  The Warren Daily The Global Atezolizumab Market report provides Insightfull basic overview of the market. The analysis highlights opportunity and Atezolizumab industry trends ... The Warren Daily
Tue, 19 Mar 2019 07:53:38 GMT
Global Tecentriq Market Consumption Status and Prospects with Brand Manufactures are Genentech , and many more  The Warren Daily The Global Tecentriq Market report provides Insightfull basic overview of the market. The analysis highlights opportunity and Tecentriq industry trends that's ... The Warren Daily
Tue, 19 Mar 2019 14:59:34 GMT
Affimed lands milestone from Roche; Puma touts new PHII data on cervical cancer  Endpoints News ... → While Affimed $AFMD works to shake off the FDA hold on its Phase I program, the team is still making preclinical progress with its innate cell ... Endpoints News
Wed, 27 Feb 2019 08:00:00 GMT
Genentech Profits Off Wasteful Cancer Drug Vials, Suit Says  Law360 Law360 (February 27, 2019, 6:48 PM EST) -- Genentech Inc. knowingly packages excessive amounts of its pricey cancer pharmaceuticals in vials that can be ... Law360
Mon, 11 Mar 2019 12:58:49 GMT
Judge Grants Preliminary Injunction in Biosimilar Trade Secret Case  The Center for Biosimilars This month, US District Judge William Alsup granted biologic developer Genentech some relief in its civil case against biosimilar developer JHL. The Center for Biosimilars
Tue, 19 Feb 2019 08:00:00 GMT
FDA Grants Priority Review to Genentech's Personalized Medicine Entrectinib  Business Wire Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), today announced that the U.S. Food and Drug Administration (FDA) has accepted ... Business Wire
Tue, 19 Mar 2019 04:12:57 GMT
Women's History Month: Top Influential Women in Biopharma  BioSpace March is National Women's Month with March 8 specifically designated as International Women's Day. Although this is not remotely a comprehensive list, ... BioSpace
Tue, 12 Mar 2019 12:25:00 GMT
Two Years After Launch of Genentech's Ocrevus, US Neurologists Report a Significant and Persistent Increase in the Treatment of Patients with Primary Progressive Multiple Sclerosis  PRNewswire EXTON, Pa., March 12, 2019 /PRNewswire/ -- Expanding adoption of Genentech's Ocrevus among US neurologists has significantly and persistently increased ... PRNewswire
Tue, 19 Mar 2019 05:24:24 GMT
Genetic Testing Global Market 2019:2024 – Daan Diagnostics Ltd, Genentech Inc., Eastern Biotech  Global Industry Journal Report Title Global Genetic Testing Market Report 2019 covers detailed competitive outlook and systematic framework of Genetic Testing market at a global ... Global Industry Journal
Fri, 22 Feb 2019 08:00:00 GMT
New Smartphone App Helps MS Patients Self Monitor Their Condition  DARKDaily.com - Laboratory News Feb 22, 2019 | Laboratory Instruments & Laboratory Equipment, Laboratory Management and Operations, Laboratory News, Laboratory Operations, Laboratory ... DARKDaily.com - Laboratory News
Sun, 17 Mar 2019 14:09:44 GMT
Global Injectable Anticoagulants Market 2019 Size & Forecast: Players Company Genentech (Roche), Sanofi, Boehringer Ingelheim  Global Industry Journal Global Injectable Anticoagulants Market Report 2019 enfolds reliable, authentic, and precise analysis of the global Injectable Anticoagulants industry that ... Global Industry Journal
Tue, 05 Mar 2019 16:52:15 GMT
Genentech’s Actemra Not Linked to Higher Risk of Infection in Children With sJIA or pcJIA, Trials Show  Juvenile Arthritis News Genentech's Actemra (tocilizumab), a medicine approved for the treatment of certain types of juvenile idiopathic arthritis (JIA), is not linked to a higher risk of ... Juvenile Arthritis News
Mon, 18 Feb 2019 08:00:00 GMT
BRIEF-Roche: FDA Grants Priority Review To Genentech’S Entrectinib  Reuters Feb 19 (Reuters) - Roche Holding AG: * GENENTECH ANNOUNCED THAT U.S. FOOD AND DRUG ADMINISTRATION (FDA) HAS ACCEPTED COMPANY'S ... Reuters
Tue, 12 Mar 2019 17:56:02 GMT
FDA Grants New Breast Cancer Indication for Genentech's Tecentriq  Specialty Pharmacy Continuum The FDA granted a new indication for Tecentriq plus chemotherapy for the treatment of adults with unresectable locally advanced or metastatic triple-negative ... Specialty Pharmacy Continuum
Mon, 18 Feb 2019 08:00:00 GMT
BRIEF-Roche: FDA Grants Priority Review To Genentech’S Polatuzumab Vedotin  Reuters Feb 19 (Reuters) - Roche Holding AG: * FDA GRANTS PRIORITY REVIEW TO GENENTECH'S POLATUZUMAB VEDOTIN IN PREVIOUSLY TREATED ... Reuters
Thu, 07 Mar 2019 08:00:00 GMT
Genentech Submits Supplemental New Drug Application to FDA for Venclexta Plus Gazyva for Previously Untreated Chronic Lymphocytic Leukemia with Co-Existing Medical Conditions  Business Wire Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), today announced the submission of a supplemental New Drug Application to the ... Business Wire
Tue, 12 Mar 2019 23:06:21 GMT
Court Enters Preliminary Injunction Against JHL In Biosimilar Trade Secrets Case  JD Supra As we previously reported, in October 2018, Genentech brought claims against Taiwan-based biosimilar developer JHL Biotech, Inc. and individual defendants ... JD Supra
Thu, 07 Mar 2019 08:00:00 GMT
BRIEF-Genentech Submits sNDA For Venclexta+Gazyva For Previously Untreated Chronic Lymphocytic Leukemia  Reuters March 7 (Reuters) - Genentech: * GENENTECH SUBMITS SUPPLEMENTAL NEW DRUG APPLICATION TO FDA FOR VENCLEXTA PLUS GAZYVA FOR ... Reuters
Fri, 08 Mar 2019 22:36:21 GMT
Genentech submits sNDA for Venclexta plus Gazyva for previously untreated CLL  The Cancer Letter Publications Genentech announced the submission of a supplemental New Drug Application to FDA for Venclexta (venetoclax) in combination with Gazyva (obinutuzumab) ... The Cancer Letter Publications
Tue, 26 Feb 2019 08:00:00 GMT
AC Immune (NASDAQ:ACIU) In Partnership With Genentech Announce Enrolment Of Patients In Phase II Trial Of Anti-Tau Monoclonal Antibody  FDA Headlines Feb 26, 2019 | Business. AC Immune (NASDAQ:ACIU) In Partnership With Genentech Announce Enrolment Of Patients In. AC Immune SA (NASDAQ:ACIU) ... FDA Headlines
Thu, 07 Mar 2019 08:00:00 GMT
Roche Study Shows AI Can Detect Severity of Diabetic Macular Edema  BioSpace The study showed that artificial intelligence can be used to provide widespread, cost-effective eye screenings via telemedicine to assist ophthalmologists in ... BioSpace
Tue, 19 Mar 2019 07:34:32 GMT
Insider Threats: How to Stop the Most Common and Damaging Security Risk You Face  Security Today Since each insider threat is very different, preventing them is challenging. Security Today
Tue, 19 Mar 2019 12:00:00 GMT
The Marriage of Big Pharma and Biotech  R & D Magazine Facing declining R&D returns and rising costs, large pharmaceutical companies are turning to the biotechnology sector more than ever before. R & D Magazine
Fri, 15 Mar 2019 10:40:06 GMT
Global Injectable Drug Delivery Technology Market 2019 Analysis by Top Industries – Alkermes Inc., Genentech Inc, Bend Research  Market Research Journal Global Injectable Drug Delivery Technology Market 2019 research report published by MRS Research Group with more than 100 industry informative desk and ... Market Research Journal
Tue, 05 Mar 2019 08:00:00 GMT
BRIEF-FDA Accepts Genentech's Supplemental New Drug Application For Xofluza  Reuters March 6 (Reuters) - Genentech: * FDA ACCEPTS GENENTECH'S SUPPLEMENTAL NEW DRUG APPLICATION FOR XOFLUZA (BALOXAVIR MARBOXIL) FOR ... Reuters
Tue, 19 Mar 2019 12:30:00 GMT
Global Injectable Anticoagulants Market Projection 2019-2026 – Genentech (Roche), Sanofi, Boehringer Ingelheim  Market Talk News Home · Information Technology; Global Injectable Anticoagulants Market Projection 2019-2026 – Genentech (Roche), Sanofi, Boehringer Ingelheim. Injectable ... Market Talk News
Mon, 18 Mar 2019 22:04:57 GMT
Atezolizumab Shows Comparable Real-World Tolerability, Efficacy in Urothelial Carcinoma  OncLive Atezolizumab (Tecentriq) demonstrated consistent safety and efficacy with prior studies of the PD-L1 inhibitor in patients with locally advanced or metastatic ... OncLive
Tue, 19 Mar 2019 10:37:00 GMT
Growing Factor of Dermatology Diagnostic Devices and Therapeutics Market|Key Leaders- Agfa-Gevaert NV, Astellas Pharma, Inc., Cutera, Inc., Dino-Lite Europe/IDCP BV, Galderma SA, Genentech,Roche  openPR This report on the Global Dermatology Diagnostic Devices and Therapeutics Market analyzes the current and future prospects of the market. The report ... openPR
Thu, 24 Jan 2019 08:00:00 GMT
Genentech Brings Back One of Its Own as Next CEO  BioSpace After Bill Anderson moved from the role of Genentech chief executive officer to helm parent company Roche's division Roche Pharmaceuticals earlier this month, ... BioSpace
Fri, 25 Jan 2019 08:00:00 GMT
Genentech names new CEO amid exec shuffling  BioPharma Dive Alexander Hardy has been appointed as CEO of Roche subsidiary Genentech, effective March 1, 2019, following Bill Anderson's move to head up Roche ... BioPharma Dive
Fri, 25 Jan 2019 08:00:00 GMT
New CEO completes round trip through Roche back to Genentech  San Francisco Business Times Alexander Hardy will be the seventh CEO of Genentech since the South San Francisco-based company was founded nearly 43 years ago and the fourth since ... San Francisco Business Times
Mon, 10 Dec 2018 08:00:00 GMT
Roche vet named Gilead CEO — and Genentech boss moves to Switzerland — in shuffle of top Bay Area biotech execs  San Francisco Business Times As Daniel O'Day takes the helm of Gilead, replacing longtime Chairman Bill Martin and CEO Bill Milligan, Roche will moves Genentech CEO into O'Day's old ... San Francisco Business Times
Wed, 20 Feb 2019 08:00:00 GMT
FDA grants priority review to three oncology therapies  Healio The FDA granted priority review to three drugs in development for oncology indications.The designations apply to use of: Healio
Wed, 02 Jan 2019 08:00:00 GMT
Genentech Cutting More Jobs in Bay Area  BioSpace On December 19, South San Francisco-based Genentech, a Roche company, filed with the State of California, indicating it planned to cut 83 jobs. BioSpace
Mon, 11 Mar 2019 14:01:00 GMT
Susan G. Komen® Announces New Funding Opportunity Focused on Better Understanding of Breast Cancer Disparities  Business Wire Susan G. Komen® announced a new effort to better understand and address why certain populations of breast cancer patients have different outcomes. Business Wire
Fri, 01 Mar 2019 08:00:00 GMT
FDA Approves New Formulation of Herceptin  Clinical Oncology News The FDA approved trastuzumab and hyaluronidase-oysk injection for subcutaneous use (Herceptin Hylecta, Genentech) It is indicated for the treatment of HER2 ... Clinical Oncology News
Wed, 06 Feb 2019 08:00:00 GMT
Genentech Uses Virtual Reality to Train Eye Surgeons  The Wall Street Journal Genentech, a division of Roche Holding AG, is using virtual reality as a training tool for eye surgeons in a clinical trial that executives expect will be the ... The Wall Street Journal
Fri, 04 Jan 2019 08:00:00 GMT
Genentech, Adaptive Bio Join Forces on Personalized Cancer Drugs R&D  Xconomy Genentech is paying Adaptive Biotechnologies $300 million up front in a new partnership focused on developing cancer immunotherapies personalized to. Xconomy
Mon, 25 Feb 2019 08:00:00 GMT
Spark Therapeutics Enters into Definitive Merger Agreement with Roche  GlobeNewswire Roche to acquire Spark Therapeutics for $114.50 per share representing a total equity value of $4.8 billion. Spark Therapeutics will continue its operations in ... GlobeNewswire
Tue, 19 Mar 2019 08:00:00 GMT
Purpose in action: the secret to building and sustaining high-performance organizations  GreenBiz In the past year alone, individuals wrote a whopping total of 669 articles about building purpose-driven organizations. I like that number — it shows how much ... GreenBiz
Mon, 10 Dec 2018 08:00:00 GMT
Roche Taps Genentech Chief to Lead Pharmaceuticals Division  The Wall Street Journal Roche Holding AG RHHBY -0.29% on Monday appointed Bill Anderson, head of its Genentech unit, to lead the company's broader pharmaceuticals business, ... The Wall Street Journal
Tue, 05 Feb 2019 08:00:00 GMT
Genentech to Develop Xencor IL-15 Cytokines in Immuno-Oncology Partnership  Genetic Engineering & Biotechnology News Genentech, a member of the Roche group, will partner with Xencor to develop and commercialize its novel IL-15 cytokine therapeutics—including its most ... Genetic Engineering & Biotechnology News
Tue, 19 Mar 2019 16:56:17 GMT
NewLink Genetics (NLNK) Reaches $2.13 After 9.00% Up Move; L & S Advisors Has Cut By $4.57 Million Its Thermo Fisher Scientific (TMO) Stake  Standard Recorder The stock of NewLink Genetics Corporation (NASDAQ:NLNK) is a huge mover today! The stock increased 12.70% or $0.24 during the last trading session, ... Standard Recorder
Tue, 30 Oct 2018 07:00:00 GMT
Genentech staff 'funneled secrets to Taiwan biosimilar firm,' prosecutors say  FierceBiotech Genentech is the latest biopharma company to be involved in an industrial espionage case, with four former U.S. researchers accused of passing sensitive ... FierceBiotech
Wed, 30 Jan 2019 08:00:00 GMT
Genentech kills big drug study in early Alzheimer's patients  San Francisco Business Times Genentech's Alzheimer's-fighting drug failed two late-stage studies, but other Bay Area companies are continuing with different approaches to the ... San Francisco Business Times
Mon, 18 Mar 2019 07:07:29 GMT
Breakthrough Therapy Drugs Market Study 2018-19 by Companies AbbVie, Genentech, Novartis, Pfizer  The Market Research News Breakthrough Therapy Drugs Market presents overview: A recent market report published on the “Breakthrough Therapy Drugs Market” presents an in-depth ... The Market Research News
Fri, 09 Nov 2018 08:00:00 GMT
Genentech details claims Sanofi partner JHL used stolen trade secrets to develop rival drugs at an 'astonishing pace'  Endpoints News The feds recently rounded up and charged a group of four, including a longtime senior scientist, with stealing trade secrets from Genentech in South San ... Endpoints News
Thu, 16 Aug 2018 07:00:00 GMT
Roche's Genentech planning to lay off 223 employees  BioPharma Dive Genentech will be laying off 223 employees located in its South San Francisco, California, headquarters beginning at the end of this month, the company ... BioPharma Dive
Tue, 19 Mar 2019 09:54:29 GMT
Global Interleukin 1 Receptor Associated Kinase 4 Market Size 2018-19 By Players Merck, Genentech, TG Therapeutics  industryreports24.com The QY Market Study gives the brief research report of the “ Interleukin 1 Receptor Associated Kinase 4 Market” around the globe. The study of reports gives ... industryreports24.com
Tue, 27 Nov 2018 08:00:00 GMT
Giant Roche wades into the preclinical NLRP3 pool, bagging Jecure for their anti-inflammatory team at Genentech  Endpoints News You can now count the biopharma giant Roche among the growing number of players fascinated by the potential of NLRP3 inhibition. James Sabry, Genentech. Endpoints News
Wed, 01 Aug 2018 07:00:00 GMT
Genentech I/O chief Dan Chen heads to an upstart biotech looking to create a landmark advance on antibodies  Endpoints News One of the top scientific leaders behind the emergence of PD-1/L1 checkpoint inhibitors has left Genentech to take the chief medical officer's job at a low-profile ... Endpoints News
Mon, 15 Oct 2018 07:00:00 GMT
Genentech plans office in Lloyd District  OregonLive.com Genentech says it will open an office in Portland's Lloyd District and hire 300 people. The California company, owned by the Swiss-based Roche Group, already ... OregonLive.com
Mon, 24 Dec 2018 08:00:00 GMT
Charter seeking to ferry Genentech workers from San Leandro dock  East Bay Times SAN LEANDRO — Genentech workers could commute to work from the San Leandro marina on a private ferry if the city approves the charter company's request. East Bay Times
Wed, 24 Oct 2018 07:00:00 GMT
The FDA Just Approved the First New Flu Drug in 20 Years—And Is Nearing an All-Time Drug Approval Record  Fortune The FDA on Wednesday approved Genentech and Shionogi's new flu drug. The agency is now on pace to have a record breaking year of approvals. Fortune
Mon, 04 Feb 2019 08:00:00 GMT
Genentech's Personalized Cancer Vaccine  DARKDaily.com - Laboratory News Genentech researchers are developing customized cancer vaccines that are based on the characteristics of each individual patient's tumor DNA. DARKDaily.com - Laboratory News
Sat, 08 Dec 2018 08:00:00 GMT
Genentech Sues JHL for Criminal Theft of Trade Secrets in Civil Court  The Center for Biosimilars In late October 2018, former Genentech employees were charged with criminal theft for conspiring to steal trade secrets to assist biosimilar developer JHL ... The Center for Biosimilars
Thu, 07 Feb 2019 08:00:00 GMT
Humble Beginnings: The Origin Story of Modern Biotechnology  Labiotech.eu The history of modern biotechnology began around four decades ago, with the invention of genetic engineering. In this piece, we explore how Genentech, one of ... Labiotech.eu
Mon, 19 Nov 2018 08:00:00 GMT
Genentech to pay Immunocore $100M to co-develop preclinical MAGE-A4 drug  FierceBiotech Genentech has put up $100 million (€88 million) in upfront and near-term milestone payments to co-develop an anticancer bispecific antibody with Immunocore. FierceBiotech
Sat, 05 Jan 2019 08:00:00 GMT
How Genentech, Badger Balm and Dr. Bronner's use sustainability to improve the environment and company culture  GreenBiz The following is an excerpt from "Green Wisdom: A Guide for Anyone to Start, Engage and Energize a Sustainability Team," authored by Nikki Pava (foreword for ... GreenBiz
Tue, 19 Mar 2019 15:22:50 GMT
Central Garden & Pet Company (CENT) Reaches $28.77 52-Week Low; Tracon Pharmaceuticals (TCON) Sellers Increased By 73.68% Their Shorts  The FinHeadLines The stock of Central Garden & Pet Company (NASDAQ:CENT) hit a new 52-week low and has $26.18 target or 9.00% below today's $28.77 share price. The FinHeadLines
Wed, 15 Aug 2018 07:00:00 GMT
As biosimilars loom, Roche's Genentech plans to lay off 223 staffers in California  FiercePharma As Roche braces for the biosimilar assault on blockbuster cancer drugs, its Genentech unit is parting ways with 223 staffers in California. FiercePharma
Mon, 18 Mar 2019 08:46:21 GMT
Pneumococcal Vaccine Market to Witness Massive Growth by Key Players: Pfizer, Sanofi, GSK, Merck, Eli Lilly  Operanewsnow HTF MI released a new market study on Global Pneumococcal Vaccine Market with 100+ market data Tables, Pie Chat, Graphs & Figures spread through Pages ... Operanewsnow
Mon, 17 Dec 2018 08:00:00 GMT
Proteostasis's stock jumps after license deal with Genentech  MarketWatch Shares of Proteostasis Therapeutics Inc. soared 13% in premarket trade Monday, after the biopharmaceutical company said it entered a licensing deal with... MarketWatch
Sun, 12 Aug 2018 07:00:00 GMT
Want a lower tax bill? So do Apple and Genentech  San Francisco Chronicle For-profit companies don't typically downplay the value of their assets. But when it comes to paying property taxes, some of Silicon Valley's largest companies ... San Francisco Chronicle
Wed, 28 Nov 2018 08:00:00 GMT
Genentech Takes Aim at NASH, Acquires Jecure Therapeutics  BioSpace Roche subsidiary Genentech snaps up Jecure and its portfolio of preclinical NLRP3 inhibitors aimed at serious inflammatory diseases. BioSpace
Thu, 08 Nov 2018 08:00:00 GMT
Citing 'brazen' trade secrets theft, Genentech sues indicted ex-employees and biosim maker  FiercePharma Genentech filed a lawsuit against former employees accused of stealing trade secrets for developing and producing some of its top drugs, calling on a court to ... FiercePharma
Mon, 04 Feb 2019 08:00:00 GMT
Genentech files flurry of lawsuits to protect $100,000-a-year drug  San Francisco Business Times Genentech bought InterMune and the Brisbane company's idiopathic pulmonary fibrosis drug Esbriet for more than $8 billion in fall 2014. Now it faces pressure ... San Francisco Business Times
Fri, 28 Dec 2018 08:00:00 GMT
Layoffs hit Instacart, Genentech, Rolls-Royce and other SF employers - San Francisco Business Times  San Francisco Business Times Across the Bay Area, pink slips were flying at Genentech, Rolls-Royce, Instacart, Oakland International Airport concessionaire HMSHost, Infinera, Spectra ... San Francisco Business Times
Wed, 21 Nov 2018 08:00:00 GMT
Genentech's inhaled JAK1 inhibitor shows promise as a localized treatment for asthma  FierceBiotech Numerous JAK inhibitors have been developed to treat inflammatory diseases. To avoid some common side effects seen in systemic JAK inhibition, Genentech ... FierceBiotech
Tue, 17 Jul 2018 07:00:00 GMT
Genentech Flu Drug Scores Another Late-Stage Win  BioSpace With flu season fast approaching, Genentech has some good news for people who are at high risk of complications from the illness. BioSpace
Thu, 24 Jan 2019 08:00:00 GMT
Alexander Hardy tapped to head back to South San Francisco as the next CEO at Genentech  Endpoints News The cross pollinization of executives between Roche and its big biotech subsidiary Genentech is continuing today with news that the South San Francisco ... Endpoints News
Tue, 16 Oct 2018 07:00:00 GMT
Sanofi, Genentech Both Eye US Expansions; Could Add up to 2300 Jobs  BioSpace Two well-established pharma companies are expanding in two different U.S. cities. One city is known for the plethora of pharma and biotech jobs, while the other ... BioSpace
Mon, 07 Jan 2019 08:00:00 GMT
Adaptive Biotechnologies and Genentech Launch Personalized Cancer-Care Program Worth $2 Billion+  BioSpace Seattle-based Adaptive Biotechnologies forged a collaboration with Genentech that could be worth up to $2 billion to develop and commercialize novel ... BioSpace
Thu, 14 Mar 2019 12:32:00 GMT
Global Plasminogen Market Growth 2019: Genentech (Roche), Boehringer Ingelheim, Prometic and Kedrion.  Healthcare Reports Global Plasminogen Market 2019 Growth Analysis, Share, Demand by Regions, Types, and Analysis of Key Players Research Forecasts to 2024. Healthcare Reports
Fri, 17 Aug 2018 07:00:00 GMT
Roche's Genentech to cut 223 jobs in California  Becker's Hospital Review Genentech, a subsidiary of Swiss pharma giant Roche, is slashing 223 jobs from its headquarters in California, according to a recent WARN notice. Becker's Hospital Review
Wed, 06 Jun 2018 07:00:00 GMT
Genentech, Microbiotica to Develop Microbiome-Based IBD Treatments  Genetic Engineering & Biotechnology News Companies agree to discover, develop, and commercialize microbiome-based biomarkers and therapies for inflammatory bowel disease, through a ... Genetic Engineering & Biotechnology News
Thu, 27 Dec 2018 13:38:59 GMT
Genentech, system upgrade high on Solano assessor-recorder’s 2019 to-do list  Fairfield Daily Republic FAIRFIELD — Marc Tonnesen has worn the hats of the assessor-recorder and assistant assessor-recorder before. He will start 2019 with the same dual role, but ... Fairfield Daily Republic
Mon, 27 Aug 2018 07:00:00 GMT
Affimed Announces Collaboration with Genentech to Develop Novel NK Cell Engager-based Immunotherapeutics for Multiple Cancer Targets  GlobeNewswire Affimed will receive $96 million upfront and committed funding and is eligible for up to an additional $5.0 billion including milestone payments, and royalties on ... GlobeNewswire
Tue, 19 Mar 2019 10:15:00 GMT
Global Growth Factors (Blood and Tissue) Market Research Report, Key Players are-Genentech, Lonza Group (Switzerland), Merck Serono (Germany), Sanofi (France) and forecast to 2025  openPR The market for Growth Factors is growing with the expansion of this Industry Sector Worldwide. Market Research Hub (MRH) has added a new report titled ... openPR
Tue, 19 Mar 2019 11:40:00 GMT
The Daily Biotech Pulse: FDA Nod For Roche And Amphastar, Milestone Payment Kicks In For Affimed  Benzinga Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks hitting 52-week highs on March 18) ... Benzinga
Mon, 28 Jan 2019 08:00:00 GMT
Hardy returns to Genentech as CEO  PMLiVE A familiar face is set to return to Genentech after the company announced that it has found a new chief executive officer. Alexander Hardy (pictured below) will ... PMLiVE
Mon, 15 Oct 2018 07:00:00 GMT
Exclusive: Genentech to open Portland office, brings 300 jobs  Portland Business Journal The biotechnology company evaluated 10 other cities before selecting Portland. Portland Business Journal
Tue, 19 Mar 2019 08:40:00 GMT
Public Health Market with AbbVie, Celgene, Galapagos, Genentech, Gilead, Johnson & Johnson, Mesoblast, RedHill Biopharma, Shire, Takeda, TiGenix, UCB  openPR Health marketing is a new, customer-centered, approach to public health promotion that applies traditional marketing principles and theories alongside ... openPR
Thu, 14 Feb 2019 08:00:00 GMT
Genentech executive helps recruit more diversity - San Francisco Business Times  San Francisco Business Times Sara Kenkare-Mitra has worked at Genentech for over 20 years, working her way up from scientist to senior vice president. San Francisco Business Times
Tue, 25 Sep 2018 07:00:00 GMT
Genentech's Tecentriq Continues to Demonstrate Its Potency as a Treatment for Lung Cancer  BioSpace This morning, Genentech released results of its Phase III IMpower 133 trial that showed treatment with Tecentriq plus chemotherapy helped people with ... BioSpace
Tue, 19 Mar 2019 05:50:00 GMT
Swiss stocks - Factors to watch on March 19  Reuters Here are some of the main factors that may affect Swiss stocks on Tuesday: Reuters
Wed, 17 Oct 2018 07:00:00 GMT
We can now customize cancer treatments, tumor by tumor  MIT Technology Review The first time someone pitched Genentech's senior leadership on a personalized cancer vaccine, it did not go well. “I thought there was going to be a riot,” Ira ... MIT Technology Review
Tue, 18 Sep 2018 07:00:00 GMT
Genentech and Hemophilia Patients Eye Oct. 4 for Hemlibra Ruling  BioSpace Hemophilia patients could have an easier time taking their medication if the U.S. Food and Drug Administration (FDA) gives the green light for the newest ... BioSpace
Thu, 13 Sep 2018 07:00:00 GMT
New Flu Season, New Flu Drug from Genentech  BioSpace Last year's influenza season in the U.S. had record-breaking hospitalization rates. A lot of industry observers are looking at a new flu drug, baloxavir marboxil, ... BioSpace
Wed, 15 Aug 2018 07:00:00 GMT
Apple, Genentech hold up Silicon Valley for billions on property tax  Curbed SF Silicon Valley's boom times mean that county coffers are booming too, as all of that private success can lead to a fat annual bill when it's time to pay the taxman. Curbed SF
Thu, 30 Aug 2018 07:00:00 GMT
Allied with Genentech and Pfizer on discovery deals, protein degradation crew at Arvinas looks for $100M IPO ahead of PhI start  Endpoints News The next wave of biotech IPOs is starting to swell today as the protein degradation crew at Arvinas jumps in with a $100 million offering. And once again we're ... Endpoints News
 

Genentech Videos

Genentech
02:09:07
Genentech
Discovering Talent for Genentech
22:50:09
Discovering Talent for Genentech
Genentech’s Herbert W. Boyer and Bill Anderson I Fortune
18:50:40
Genentech’s Herbert W. Boyer and Bill Anderson I Fortune
How Biotech Began--The Story of Genentech
20:12:47
How Biotech Began--The Story of Genentech
Genentech Job Shadow Day
23:08:42
Genentech Job Shadow Day
Making Medicines in 360
17:30:58
Making Medicines in 360
Oncology Biomarker Development at Genentech
22:00:02
Oncology Biomarker Development at Genentech
A Place for New Perspectives
23:30:01
A Place for New Perspectives
Genentech's story
23:13:41
Genentech's story
Genentech IT: Why Work Anywhere Else?
17:51:52
Genentech IT: Why Work Anywhere Else?
 

Genentech Images

High Performance Alliances - Beam, Inc.
High Performance Alliances - Beam, Inc.
Genentech Founders Statue | Bronze Life-size Sculptures of ...
Genentech Founders Statue | Bronze Life-size Sculptures of ...
The 30 Best Workplaces in Health Care | Fortune
The 30 Best Workplaces in Health Care | Fortune
Cover Letter Examples by Real People: Diversity manager ...
Cover Letter Examples by Real People: Diversity manager ...
Apoptosis and BCL-2 » XVIVO Scientific Animation
Apoptosis and BCL-2 » XVIVO Scientific Animation
Marilu Henner Encourages Tough Talks on Bladder Cancer ...
Marilu Henner Encourages Tough Talks on Bladder Cancer ...
Loveland Artist’s Work, Inspired by Cancer Cells ...
Loveland Artist’s Work, Inspired by Cancer Cells ...
Linda A. Curtis - BookSparks
Linda A. Curtis - BookSparks
Multiple Choice on Human Genome Project (HGP) ~ MCQ ...
Multiple Choice on Human Genome Project (HGP) ~ MCQ ...
Ocrevus - FDA prescribing information, side effects and uses
Ocrevus - FDA prescribing information, side effects and uses
 

Genentech WebSites

 

Genentech Wiki

Genentech, Inc., is a biotechnology corporation which became a subsidiary of Roche in 2009. Genentech Research and Early Development operates as an independent center within Roche.As of February 2019, Genentech employed 13,697 people.

LabCorp

Sauer Danfoss

yuma

arm wrestling

Chuck E CheesesThe Georgetown Voice Well, Shane Dawsons done it againf youre not familiar with the 30-year-old YouTuber, Dawson gained popularity in the late 2000s on the video-sharing site

omni air international

Sonic Drive In

water polo

Old Dominion Freight Line

Kennametal